Table 1 Baseline characteristics
From: Detecting exacerbations using the Clinical COPD Questionnaire
Baseline characteristics | Patients with an exacerbation | Patients without an exacerbation |
|---|---|---|
No. of patients | 69 | 34 |
Gender | ||
male n (%) | 42 (60) | 20 (58.8) |
Age, yr | 67 ± 9.8 | 65 ± 11.1 |
Current smoker n (%) | 19 (27) | 7 (21) |
Smoking pack years (IQR) | 37 (15-50) | 37.5 (1-43.3) |
FEV1 (% of predicted) | 46.0 ± 18.4 | 51.1 ± 21.0§ |
FEV1/FVC | 0.44 ± 0.13 | 0.47 ± 0.12 |
GOLD Classification of COPD n (%) | ||
stage I: mild | 4 (5.8) | 4 (11.8) |
stage II: moderate | 24 (34.8) | 10 (29,4) |
stage III: severe | 27(39.1) | 16 (47,1) |
stage IV: very severe | 14 (20.3) | 4 (11.8) |
MRC dyspnea | 3 (2-4) | 3 (2-4) |
Contact reason at inclusion n (%) | ||
regular check-up | 36 (51.4) | 13 (38.2) |
emergency department | 2 (2.9) | 0 (0) |
during hospitalisation | 14 (20) | 5 (14.7) |
check-up after hospitalisation | 1 (1.4) | 1 (2.9) |
during pulmonary rehabilitation | 16 (22.9) | 15 (44.1) |